Ingelvac PRRS MLV

Porcine Reproductive and Respiratory Syndrome Vaccine

Reproductive and Respiratory Forms, Modified Live Virus

This product has been shown to be effective for the vaccination of healthy swine 3 weeks of age or older against reproductive and respiratory disease caused by Porcine Reproductive and Respiratory Syndrome (PRRS) virus. The duration of immunity is at least 4 months. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.

Recommended for use in healthy swine in PRRS virus positive herds only, per labeled directions.

Directions and dosage: Rehydrate only with the diluent provided; do not mix with other materials. Other diluents may be viricidal.

Insert a vented transfer spike into the enclosed Sterile Diluent bottle. Invert the Ingelvac PRRS MLV bottle over the diluent and slowly insert the transfer spike into the Ingelvac PRRS MLV vaccine bottle, releasing the vacuum. Rotate the bottles and transfer a portion of the diluent to the vaccine vial, sufficient to rehydrate the Ingelvac PRRS MLV vaccine. Again rotate the bottles, still attached by transfer spike, to transfer the reconstituted suspension back into the diluent bottle. Mix with the remaining diluent to complete the total volume. Shake well and use immediately.

Sows and gilts: Using aseptic technique, inject a single 2 mL dose intramuscularly for the reproductive form of PRRS. Sows and gilts may be vaccinated prior to breeding or at any stage of pregnancy. Vaccination can either be population-targeted as a whole-herd vaccination program where all pregnant and nonpregnant sows and gilts are vaccinated every 3-4 months, or individual animal-targeted by vaccination 3 to 4 weeks prior to each breeding, or as directed by your herd veterinarian. Piglets: Using aseptic technique, inject a single 2 mL dose intramuscularly for the respiratory form of PRRS.

Precautions

Store out of direct sunlight at 35-46°F (2-8°C). Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Do not mix with other products, except as specified on the label. In case of anaphylactoid reaction, administer epinephrine. Do not vaccinate breeding age boars. In case of human exposure, contact a physician. Inactivate unused contents before disposal.

Vaccine virus may be shed and transmitted to other populations of swine in contact with vaccinated swine. The duration of potential vaccine virus transmission may vary. Use of the vaccine in herds intended to remain PRRS virus seronegative is contraindicated. Specific herds may be particularly sensitive. Introduction of vaccinated pigs into herds intended to remain PRRS virus seronegative is contraindicated.

Preservative: Neomycin.

Ingelvac PRRS^® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Used under license.

Boehringer Ingelheim Animal Health USA Inc., St. Joseph, MO 64506

Phone: 1 (888) 637-4251

VLN/PCN 124/19T1.20

10 Doses Rehydrate with 20 mL	This package contains one 10 dose vial of vaccine and one 20 mL vial of sterile diluent.	124534-12
50 Doses Rehydrate with 100 mL	This package contains one 50 dose vial of vaccine and one 100 mL vial of sterile diluent.	124535-13
250 Doses Rehydrate with 500 mL	This package contains one 250 dose vial of vaccine and one 500 mL vial of sterile diluent.	1245139-03

CPN: 1028068.5